Mepolizumab

含有 Mepolizumab 的品牌、食物注意事项以及最重要的药物相互作用。

品牌

NUCALA 100 MG SC ENJEKSIYONLUK COZELTI ICIN LIYOFILIZE TOZ (1 FLAKON)条形码：8699522779987
NUCALA 100 MG/ML SC ENJEKSIYONLUK COZELTI IÇEREN KULLANIMA HAZIR ENJEKTOR (1 ADET)条形码：8699522958542
NUCALA 100 MG/ML SC ENJEKSIYONLUK COZELTI IÇEREN KULLANIMA HAZIR KALEM (1 ADET)条形码：8699522958528
NUCALA 40 MG/ML SC ENJEKSIYONLUK COZELTI ICEREN KULLANIMA HAZIR ENJEKTOR (1 ADET)条形码：8699522958566

食物注意事项

该活性成分暂无已收录的食物注意事项。

最重要的相互作用

前 10 项，共 50 项

2-Methoxyethanol中等
当 2-Methoxyethanol 与 Mepolizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Mepolizumab.
Abatacept中等
当 Abatacept 与 Mepolizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Abatacept is combined with Mepolizumab.
Abciximab中等
当 Abciximab 与 Mepolizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Abciximab is combined with Mepolizumab.
Adalimumab中等
当 Adalimumab 与 Mepolizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Adalimumab is combined with Mepolizumab.
Adecatumumab中等
当 Adecatumumab 与 Mepolizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Adecatumumab is combined with Mepolizumab.
Afelimomab中等
当 Afelimomab 与 Mepolizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Afelimomab is combined with Mepolizumab.
Aldesleukin中等
当 Aldesleukin 与 Mepolizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mepolizumab.
Aldosterone中等
当 Aldosterone 与 Mepolizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Aldosterone is combined with Mepolizumab.
Alefacept中等
当 Alefacept 与 Mepolizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Alefacept is combined with Mepolizumab.
Alemtuzumab中等
当 Alemtuzumab 与 Mepolizumab 联合使用时，发生不良反应的风险或严重程度可能增加。
专业视图
The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Mepolizumab.